Procell Biologics Private Limited, a active private limited company, was established on 14 April 2021 in Medchal Malkajgiri District, Telangana, India. Engaging in drug formulation & development within the pharma sector, it holds CIN: U24290TG2021PTC150610. Registered under ROC Roc Hyderabad. it is unlisted. It has an authorized capital of ₹11.00 Cr and a paid-up capital of ₹10.37 Cr.
Employing 52 professional, Its leadership includes Srinivasa Chowdary Akkina (Director), Srinivas Suveerji Cherukuri (Director), Muni Koteswara Rao Akkina (Director). Past directors included Sushma Barla, Megha Aggarwal. It holds ₹3.00 M open charges and no settled loans. Its latest AGM occurred on 30 September 2024, with the balance sheet filed on 31 March 2024. It is based at Building No189,2Nd Floor,Mn Park,Synergy Square 1, Genome Valley,Turkapally(V),Shamirpet(M), ,, Medchal Malkajgiri District, Telangana, 500078.
U24290TG2021PTC150610
150610
14 April 2021
₹11.00 Cr
₹10.37 Cr
Roc Hyderabad
Unlisted
Active
Explore comprehensive insights into Procell Biologics Private Limited — covering financial performance, compliance records, Competitor, shareholding patterns, directors, key metrics, and litigation history. Unlock to see detailed insights and stay informed.
Access Report
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
| Srinivasa Chowdary Akkina | Director | 14 Apr 2021 | Current |
| Srinivas Suveerji Cherukuri | Director | 14 Apr 2021 | Current |
| Muni Koteswara Rao Akkina | Director | 14 Apr 2021 | Current |
| Surya Prabhavathi Akkina | Director | 14 Apr 2021 | Current |
| Venkata Krishnaji Cherukuri | Director | 14 Apr 2021 | Current |
| Name | Designation | Cessation | Status |
|---|---|---|---|
| Pramod Abcsdd | Company Secretary | - | Past |
| Pramod Abcsdd | Company Secretary | - | Past |
Discover detailed profiles of directors and KMP - Unlock leadership insights today!
Procell Biologics Private Limited, for the financial year ended 2024, experienced significant growth in revenue, with a 56.81% increase. The company also saw a substantial fall in profitability, with a 30.46% decrease in profit. The company's net worth observed a substantial decline by a decrease of 681.38%.
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations | |||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
In 2024, Procell Biologics had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Reveal ownership structures and financial performance - Get instant access now!
₹3,000,000.00
₹0
| Date | Lender | Amount | Status |
|---|---|---|---|
| 27 Oct 2023 | Hdfc Bank Limited | ₹3.00 M | Open |
Explore comprehensive loan charge details -
Procell Biologics has a workforce of 52 employees as of Mar 11, 2025. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Gain comprehensive insights into the Deals and Valuation data of Procell Biologics, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Procell Biologics's trajectory.
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
Procell Biologics Private Limited last Annual general meeting of members was held on 30 Sep 2024 as per latest MCA records. was recorded as a recent event.
The activity Procell Biologics Private Limited has filed its annual Financial statements for the year ended 31 Mar 2024 with Roc Hyderabad. was completed.
The activity A charge with Hdfc Bank Limited amounted to Rs. 0.30 Cr with Charge ID 100827661 was registered on 27 Oct 2023. was completed.
Srinivasa Chowdary Akkina was appointed as a Director was appointed as a Director on 14 Apr 2021 & has been associated with this company since 4 years 9 months . was recorded as a recent event.
Progress on Srinivas Suveerji Cherukuri was appointed as a Director was appointed as a Director on 14 Apr 2021 & has been associated with this company since 4 years 9 months . was documented.
Muni Koteswara Rao Akkina was appointed as a Director was appointed as a Director on 14 Apr 2021 & has been associated with this company since 4 years 9 months . was recorded as a recent event.
The CIN of Procell Biologics Private Limited is U24290TG2021PTC150610.
Procell Biologics Private Limited is headquartered at Building No189,2Nd Floor,Mn Park,Synergy Square 1, Genome Valley,Turkapally(V),Shamirpet(M), ,, Medchal Malkajgiri District, Telangana, 500078.
Procell Biologics Private Limited was incorporated on 14 April 2021.
The current directors of Procell Biologics Private Limited are
The primary industry of Procell Biologics Private Limited is Pharma.
Procell Biologics Private Limited is unlisted.
The authorized capital of Procell Biologics Private Limited is ₹11.00 Cr, and the paid-up capital is ₹10.37 Cr.
Search company & director profiles for free and gain access to critical business data.
Company Details
+91-XXXXXXXXXX